News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Atherotech Diagnostics Lab Release: VAP® Cholesterol Test Helps Researchers Study Dyslipidemia, Assess Effectiveness of New Anti-flushing Agent


3/15/2012 10:05:37 AM

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Researchers using the VAP® Cholesterol Test to isolate lipid subfractions and assess a new anti-flushing agent report significant baseline reductions in the cholesterol content of lipoproteins across the entire VLDL to LDL density range in dyslipidemic patients.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES